Navigating Through Guts: A Comparative Study on COVID-19 and Amebiasis in Children
DOI:
https://doi.org/10.35516/jmj.v59i4.2496Keywords:
COVID-19, Amebiasis, diarrhea, Children, JordanAbstract
Background and Aims: The coronavirus disease 2019 (COVID-19) has global significance with a notable impact on pediatric populations, exhibiting not only respiratory but also gastrointestinal (GI) symptoms. Given that the prevalence of Entamoeba histolytica causing amebiasis in Jordan is 27.8% of annual diarrheal illnesses, our study aimed to delineate the clinical features of COVID-19 in children with a focus on GI manifestations, and to compare these features with those of amebiasis-associated diarrhea.
Materials and Methods: We conducted a retrospective cross-sectional analysis at Jordan University Hospital between September and December 2020. The study cohort included children under 18 years with a confirmed diagnosis of COVID-19, assessed for GI symptoms and compared against age-matched controls hospitalized with diarrhea but negative for COVID-19. We evaluated demographic data, clinical presentations, laboratory findings, and outcomes to differentiate between COVID-19 associated diarrhea (CAD) and amebiasis associated diarrhea (AAD).
Results: The study included 229 pediatric patients, with 25 hospitalized cases. Among these hospitalized children, 76% exhibited diarrhea, with 21% having concurrent amebiasis. There was no significant age difference between the CAD and AAD groups. Notably, vomiting and abdominal pain were more prevalent in the CAD group, although this did not translate to longer hospital stays. Furthermore, the incidence rates of amebiasis in COVID-19 positive children did not significantly differ from the control group, indicating no exacerbation of amebiasis by COVID-19.
Conclusions: Our findings suggested that while GI symptoms were prevalent among pediatric COVID-19 cases in Jordan, the clinical course of CAD appears comparable to that of AAD, without increased severity or prolonged hospitalization. However, it is important to note that the study size was small, which may limit the generalizability of our results This study underscored the importance of considering concurrent etiologies in children presenting with diarrhea during the COVID-19 pandemic and provided a foundational comparative analysis for future research on GI manifestations in pediatric infectious diseases. Further studies with larger sample sizes are needed to validate these findings and explore the full spectrum of GI symptoms in this population.
References
Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res. Jul 2020;24:91-98. doi:10.1016/j.jare.2020.03.005.
Coronavirus COVID-19 global cases by the center for systems sciences and engineering (CSSE) at Johns Hopkins univeristy. https://coronavirus.jhu.edu/map.html
worldometer statistics for coronavirus in Jordan. Accessed 20-January-2023, 2023. https://www.worldometers.info/coronavirus/country/jordan/
Lu X, Zhang L, Du H, et al. SARS-CoV-2 Infection in Children. N Engl J Med. 2020:1663-1665. vol. 17.
Belot A, Levy-Bruhl D. Multisystem Inflammatory Syndrome in Children in the United States. N Engl J Med. Oct 29 2020;383(18):1793-1794. doi:10.1056/NEJMc2026136.
Madabhavi I, Sarkar M, Kadakol N. COVID-19: a review. Monaldi Arch Chest Dis. May 14 2020;90(2). doi:10.4081/monaldi.2020.1298.
Zhang J, Garrett S, Sun J. Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19. Genes Dis. Jul 2021;8(4):385-400. doi:10.1016/j.gendis.2020.08.013.
Merola E, Armelao F, de Pretis G. Prevalence of gastrointestinal symptoms in coronavirus disease 2019: a meta-analysis. Acta Gastroenterol Belg. Oct-Dec 2020;83(4):603-615.
Health Department-Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS-C) in the United State.
Kabeerdoss J, Pilania RK, Karkhele R, Kumar TS, Danda D, Singh S. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatol Int. Jan 2021;41(1):19-32. doi:10.1007/s00296-020-04749-4.
Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. Jul 23 2020;383(4):334-346. doi:10.1056/NEJMoa2021680.
Alsuwaiti M, Alzyoud R, Maaitah H, Aladaileh B, Alnsoor H, Nobani M. Clinical and Laboratory Features of Patients with Multisystem Inflammatory Syndrome in Children (MIS-C): An Experience From Queen Rania Children's Hospital, Jordan. Cureus. Apr 2023;15(4):e37282. doi:10.7759/cureus.37282.
Kilani MM, Odeh MM, Shalabi M, Al Qassieh R, Al-Tamimi M. Clinical and laboratory characteristics of SARS-CoV2-infected paediatric patients in Jordan: serial RT-PCR testing until discharge. Paediatr Int Child Health. Sep 7 2020:1-10. doi:10.1080/20469047.2020.1804733.
Chazal AM, Adi HK. THE PREVALENCE OF INTESTINAL PARASITES IN AMMAN, JORDAN. Bulletin of Pharmaceutical Sciences Assiut University. 2007;30(2):235-239. doi:10.21608/bfsa.2007.64203.
Sahney A, Wadhawan M, Agarwal N, et al. A Case Series of Amoebic Liver Abscess in Patients With COVID-19 Infection. J Clin Exp Hepatol. © 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.; 2022:1017-1020. vol. 3.
Maricuto AL, Velásquez VL, Pineda J, et al. Amoebic liver abscess in a COVID-19 patient: a case report. BMC Infect Dis. Nov 4 2021;21(1):1134. doi:10.1186/s12879-021-06819-9.
Dorantes JA, López-Becerril JO, Zavala-Cerna MG. Fatal attraction: intestinal amebiasis and COVID-19 as risk factors for colonic perforation. J Surg Case Rep. Published by Oxford University Press and JSCR Publishing Ltd. © The Author(s) 2021.; 2021:rjab301. vol. 7.
Nemati Zargaran F, Rostamian M, Kooti S, Madanchi H, Ghadiri K. Co-infection of COVID-19 and parasitic diseases: A systematic review. Parasite Epidemiol Control. May 2023;21:e00299. doi:10.1016/j.parepi.2023.e00299.
Rezzoug I, Visseaux B, Bertine M, et al. Faecal Viral Excretion and Gastrointestinal Co-Infection Do Not Explain Digestive Presentation in COVID-19 Patients. Microorganisms. Jul 9 2023;11(7). doi:10.3390/microorganisms11071780 .
Lupia T, Corcione S, De Rosa FG. Giardiasis reactivation during severe SARS-CoV-2 infection. Parasitol Int. Feb 2021;80:102241. doi:10.1016/j.parint.2020.102241.
Abdel-Hamed EF, Ibrahim MN, Mostafa NE, et al. Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections. Gut Pathog. May 4 2021;13(1):29. doi:10.1186/s13099-021-00427-3.
Bitar RR, Alattas B, Azaz A, Rawat D, Miqdady M. Gastrointestinal manifestations in children with COVID-19 infection: Retrospective tertiary center experience. Front Pediatr. 2022;10:925520. doi:10.3389/fped.2022.925520.
Plantener E, Nanthan KR, Deding U, et al. Impact of COVID-19 Restrictions on Acute Gastroenteritis in Children: A Regional, Danish, Register-Based Study. Children (Basel). Apr 29 2023;10(5). doi:10.3390/children10050816.
Sunday AB, Nyasa RB, Mokake M. The influence of COVID-19 barrier measures on the positivity rate of typhoidal salmonellosis and amoebiasis in the Buea Health District, South West Region of Cameroon. PLOS Glob Public Health. 2023;3(4):e0001854. doi:10.1371/journal.pgph.0001854.
